Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

580 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical expression of cystic fibrosis in a large cohort of Italian siblings.
Terlizzi V, Lucarelli M, Salvatore D, Angioni A, Bisogno A, Braggion C, Buzzetti R, Carnovale V, Casciaro R, Castaldo G, Cirilli N, Collura M, Colombo C, Di Lullo AM, Elce A, Lucidi V, Madarena E, Padoan R, Quattrucci S, Raia V, Seia M, Termini L, Zarrilli F. Terlizzi V, et al. Among authors: salvatore d. BMC Pulm Med. 2018 Dec 22;18(1):196. doi: 10.1186/s12890-018-0766-6. BMC Pulm Med. 2018. PMID: 30577776 Free PMC article.
First and second wave of SARS-CoV2 in Italian Cystic Fibrosis patients: Data from Italian Cystic Fibrosis Registry.
Padoan R, Carnovale V, Salvatore D, Quattrucci S, Taruscio D, Floridia G, Amato A, Ferrari G, Campagna G, Salvatore M. Padoan R, et al. Among authors: salvatore d, salvatore m. J Cyst Fibros. 2021 Mar;20(2):372-373. doi: 10.1016/j.jcf.2021.01.008. Epub 2021 Jan 26. J Cyst Fibros. 2021. PMID: 33549520 Free PMC article. No abstract available.
Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor Therapy in Three Subjects with the Cystic Fibrosis Genotype Phe508del/Unknown and Advanced Lung Disease.
Terlizzi V, Colangelo C, Marsicovetere G, D'Andria M, Francalanci M, Innocenti D, Masi E, Avarello A, Taccetti G, Amato F, Comegna M, Castaldo G, Salvatore D. Terlizzi V, et al. Among authors: salvatore d, d andria m. Genes (Basel). 2021 Jul 29;12(8):1178. doi: 10.3390/genes12081178. Genes (Basel). 2021. PMID: 34440351 Free PMC article.
Elexacaftor/tezacaftor/ivacaftor for CFTR variants giving rise to diagnostic uncertainty: Personalised medicine or over-medicalisation?
Salvatore D, Pepe A, Carnovale V, Majo F, Padoan R, Quattrucci S, Salvatore M, Taruscio D, Amato A, Ferrari G, Campagna G. Salvatore D, et al. Among authors: salvatore m. J Cyst Fibros. 2022 May;21(3):544-548. doi: 10.1016/j.jcf.2021.09.011. Epub 2021 Sep 25. J Cyst Fibros. 2022. PMID: 34583889 Free article. No abstract available.
Effectiveness and safety of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease with the Phe508del/minimal function genotype.
Carnovale V, Iacotucci P, Terlizzi V, Colangelo C, Medio P, Ferrillo L, De Gregorio F, Francalanci M, Taccetti G, Buonaurio S, d'Ippolito M, Marsicovetere G, D'Andria M, Ferrara N, Salvatore D. Carnovale V, et al. Among authors: salvatore d, d andria m, d ippolito m. Respir Med. 2021 Nov-Dec;189:106646. doi: 10.1016/j.rmed.2021.106646. Epub 2021 Oct 12. Respir Med. 2021. PMID: 34673344 Free article.
580 results